Literature DB >> 24902621

Deletion polymorphism of GSTT1 gene as protective marker for allergic rhinitis.

Andrea Iorio1,2, Renato Polimanti1, Sara Piacentini1, Giancarlo Maria Liumbruno3, Dario Manfellotto2, Maria Fuciarelli1.   

Abstract

BACKGROUND AND AIMS: Allergic rhinitis (AR) is one of the most common respiratory diseases among human populations. Strong evidence suggests that genetic predisposition and environmental factors could contribute to the development of this complex disease. Glutathione S-transferases (GSTs) are biomarkers of inflammation and oxidative stress. These phase II enzymes play a significant role in detoxifying xenobiotic compounds. To analyze the role of GST gene polymorphisms in AR pathogenesis in a case-control population of 103 patients affected by AR and 200 healthy non-allergic subjects.
METHODS: We screened genomic DNA extracted from buccal cells for GSTM1 positive/null, GSTP1*I105V (rs1695) and GSTT1 positive/null polymorphisms. The X(2) -test, odds ratio (OR) and logistic regression were used as statistical analyses.
RESULTS: Significant differences in null genotype distribution between AR patients (13%) and healthy controls (30%) were found for the GSTT1 null genotype (OR = 0.30, 95% confidence interval = 0.14-0.65; P = 0.001). GSTM1 and GSTP1 polymorphisms did not show any significant results.
CONCLUSION: Our data indicated that GSTT1 may be a susceptibility locus for AR. Specifically, the positive/null polymorphism of GSTT1 may be involved in an oxidative stress-related mechanism that may enhance pathogenic pathways related to AR. Moreover, beside GSTT1, this deletion polymorphism affects also another gene potentially related to AR phenotype, LOC391322. This gene belongs to MIF (macrophage migration inhibitory factor) gene family and several studies indicated the role of this gene in several immunology-related phenotypes. Therefore, two different scenarios may explain the observed genetic association.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  allergy; association study; genetic predisposition; genetic variants; glutathione S-transferases; respiratory diseases

Mesh:

Substances:

Year:  2014        PMID: 24902621     DOI: 10.1111/crj.12170

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  6 in total

1.  GSTT1 and GSTM1 polymorphisms with human papillomavirus infection in women from southern Brazil: a case-control study.

Authors:  Ana Paula Reolon Bortolli; Valquíria Kulig Vieira; Indianara Carlotto Treco; Claudicéia Risso Pascotto; Guilherme Welter Wendt; Léia Carolina Lucio
Journal:  Mol Biol Rep       Date:  2022-05-04       Impact factor: 2.742

2.  Overexpression of family with sequence similarity 134, member B (FAM134B) in colon cancers and its tumor suppressive properties in vitro.

Authors:  Katherine Ting-Wei Lee; Farhadul Islam; Jelena Vider; Jeremy Martin; Anna Chruścik; Cu-Tai Lu; Vinod Gopalan; Alfred Kin-Yan Lam
Journal:  Cancer Biol Ther       Date:  2020-08-28       Impact factor: 4.742

3.  Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury.

Authors:  Jian-Tao Liu; Si Zhang; Bing Gu; Hua-Nan Li; Shuo-Yu Wang; Shui-Yin Zhang
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

Review 4.  Atypical microdeletion in 22q11 deletion syndrome reveals new candidate causative genes: A case report and literature review.

Authors:  Huiping Shi; Zhaoyue Wang
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

Review 5.  Interactions between glutathione S-transferase genes and household air pollution on asthma and lung function.

Authors:  Xin Dai; Shyamali C Dharmage; Caroline J Lodge
Journal:  Front Mol Biosci       Date:  2022-09-29

6.  Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase.

Authors:  Francisco J Sánchez-Gómez; Beatriz Díez-Dacal; Elena García-Martín; José A G Agúndez; María A Pajares; Dolores Pérez-Sala
Journal:  Front Pharmacol       Date:  2016-08-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.